Suppr超能文献

截短核苷作为A(3)腺苷受体配体:2-芳基乙炔基和双环己烷取代基的组合

Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.

作者信息

Tosh Dilip K, Paoletta Silvia, Phan Khai, Gao Zhan-Guo, Jacobson Kenneth A

机构信息

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810.

出版信息

ACS Med Chem Lett. 2012 Jul 12;3(7):596-601. doi: 10.1021/ml300107e. Epub 2012 Jun 11.

Abstract

C2-Arylethynyladenosine-5'-N-methyluronamides containing a bicyclo[3.1.0]hexane ((N)-methanocarba) ring are selective A(3) adenosine receptor (AR) agonists. Similar 4'-truncated C2-arylethynyl-(N)-methanocarba nucleosides containing alkyl or alkylaryl groups at the N(6) position were low-efficacy agonists or antagonists of the human A(3)AR with high selectivity. Higher hA(3)AR affinity was associated with N(6)-methyl and ethyl (K(i) 3-6 nM), than with N(6)-arylalkyl groups. However, combined C2-phenylethynyl and N(6)-2-phenylethyl substitutions in selective antagonist 15 provided a K(i) of 20 nM. Differences between 4'-truncated and nontruncated analogues of extended C2-p-biphenylethynyl substitution suggested a ligand reorientation in AR binding, dominated by bulky N(6) groups in analogues lacking a stabilizing 5'-uronamide moiety. Thus, 4'-truncation of C2-arylethynyl-(N)-methanocarba adenosine derivatives is compatible with general preservation of A(3)AR selectivity, especially with small N(6) groups, but reduced efficacy in A(3)AR-induced inhibition of adenylate cyclase.

摘要

含有双环[3.1.0]己烷((N)-碳环)的C2-芳乙炔基腺苷-5'-N-甲基脲苷是选择性A(3)腺苷受体(AR)激动剂。类似的在N(6)位含有烷基或烷基芳基的4'-截短的C2-芳乙炔基-(N)-碳环核苷是人类A(3)AR的低效激动剂或拮抗剂,具有高选择性。与N(6)-芳烷基相比,N(6)-甲基和乙基(K(i) 3 - 6 nM)与更高的hA(3)AR亲和力相关。然而,选择性拮抗剂15中C2-苯乙炔基和N(6)-2-苯乙基的组合取代提供了20 nM的K(i)。扩展的C2-对-联苯乙炔基取代的4'-截短和非截短类似物之间的差异表明,在AR结合中配体重新定向,在缺乏稳定的5'-脲酰胺部分的类似物中,由庞大的N(6)基团主导。因此,C2-芳乙炔基-(N)-碳环腺苷衍生物的4'-截短与A(3)AR选择性的总体保留兼容,特别是对于小的N(6)基团,但在A(3)AR诱导的腺苷酸环化酶抑制中效力降低。

相似文献

1
Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.
ACS Med Chem Lett. 2012 Jul 12;3(7):596-601. doi: 10.1021/ml300107e. Epub 2012 Jun 11.
5
Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.
Bioorg Med Chem. 2008 Sep 15;16(18):8546-56. doi: 10.1016/j.bmc.2008.08.007. Epub 2008 Aug 7.
7
Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.
Bioorg Med Chem Lett. 2008 May 1;18(9):2813-9. doi: 10.1016/j.bmcl.2008.04.001. Epub 2008 Apr 4.

引用本文的文献

1
Covalently Binding Adenosine A Receptor Agonist ICBM Irreversibly Reduces Voltage-Gated Ca Currents in Dorsal Root Ganglion Neurons.
Purinergic Signal. 2024 Feb;20(1):35-45. doi: 10.1007/s11302-023-09929-y. Epub 2023 Mar 15.
3
Interaction of A adenosine receptor ligands with the human multidrug transporter ABCG2.
Eur J Med Chem. 2022 Mar 5;231:114103. doi: 10.1016/j.ejmech.2022.114103. Epub 2022 Jan 10.
5
Evidence for the Interaction of A Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1).
Mol Pharmacol. 2019 Aug;96(2):180-192. doi: 10.1124/mol.118.115295. Epub 2019 May 24.
6
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists.
ACS Omega. 2018 Oct 31;3(10):12658-12678. doi: 10.1021/acsomega.8b01237. Epub 2018 Oct 4.
7
Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
Methods Mol Biol. 2018;1705:45-72. doi: 10.1007/978-1-4939-7465-8_3.
8
A Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.
Med Res Rev. 2018 Jul;38(4):1031-1072. doi: 10.1002/med.21456. Epub 2017 Jul 6.
10
Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.
Mol Pharmacol. 2016 Jul;90(1):12-22. doi: 10.1124/mol.116.103283. Epub 2016 May 2.

本文引用的文献

2
Controlling murine and rat chronic pain through A3 adenosine receptor activation.
FASEB J. 2012 May;26(5):1855-65. doi: 10.1096/fj.11-201541. Epub 2012 Feb 17.
3
Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration.
J Neurochem. 2012 Apr;121(2):217-27. doi: 10.1111/j.1471-4159.2012.07693.x. Epub 2012 Mar 14.
6
Pharmacological and therapeutic effects of A3 adenosine receptor agonists.
Drug Discov Today. 2012 Apr;17(7-8):359-66. doi: 10.1016/j.drudis.2011.10.007. Epub 2011 Oct 19.
7
Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.
Int J Mol Med. 2011 Nov;28(5):727-31. doi: 10.3892/ijmm.2011.753. Epub 2011 Jul 19.
9
Impact of disrupting adenosine A₃ receptors (A₃⁻/⁻ AR) on colonic motility or progression of colitis in the mouse.
Inflamm Bowel Dis. 2011 Aug;17(8):1698-713. doi: 10.1002/ibd.21553. Epub 2010 Dec 3.
10
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.
Biochem Pharmacol. 2011 Sep 15;82(6):658-68. doi: 10.1016/j.bcp.2011.06.017. Epub 2011 Jun 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验